SC&H Capital, a leading investment bank specializing in M&A advisory for middle-market companies, is pleased to announce the acquisition of its client, Allergy & Asthma Consultants Incorporated (AAC) by an affiliate of Family Allergy & Asthma (FAA), a portfolio company of Prairie Capital. FAA’s affiliated management services organization (MSO) also acquired the assets of AAC’s MSO, Lanpher Management Company (LMC).
AAC is a medical practice of allergists treating patients in Greater York and Hanover, Pennsylvania. Founded in 1986 by Dr. Gregory Lanpher, the practice diagnoses, treats, and manages multiple conditions in adults and children, including but not limited to asthma, food allergies, environmental allergies, and sinusitis. LMC is a legal entity established to provide management and staff support to the practice.
“SC&H Capital designed a process to find an acquirer that would fit our provider, staff culture, and most importantly, feel familiar for our patients and allergy community,” said Karen Lanpher, President of AAC-LMC. “I am thrilled with the outcome and, as a long-term client of SC&H Group, appreciate the care, expertise, and measured approach they bring to every engagement.”
“It was a pleasure to support Karen and the AAC-LMC team throughout this transaction and find an acquirer that aligned with their values and objectives,” said Craig Bowden, a Principal at SC&H Capital. “It further highlights the ongoing push for top-line growth for specialized provider groups, and in particular private equity-owned medical practices.”
The acquisition closed on August 9, 2021. The terms of the transaction were not disclosed.
About Family Allergy & Asthma
FAA is an allergy and asthma medical practice with locations in Arkansas, Indiana, Kentucky, Ohio, Tennessee, and now Pennsylvania. Founded in 1979 by Drs. Stephen J. Pollard and James L. Sublett, the practice has grown to include more than 50 allergists seeing patients in over 60 offices across six states. Family Allergy & Asthma’s mission is to help patients remove the limitations of their allergic and asthmatic conditions. For more information, visit FamilyAllergy.com.
About SC&H Capital
SC&H Capital is an investment banking and advisory firm specializing in mergers and acquisitions (M&A), employee stock ownership plans (ESOP), distressed M&A, and business valuations for middle-market companies nationally. SC&H Capital delivers services across numerous industries including technology, healthcare, manufacturing, business and professional services, and government contracting. We are recognized for delivering relevant market insights and tailored solutions to help owners achieve their true strategic value. To learn more, visit www.schcapital.com.